双能CT在弥漫性肝病中的应用:是否有价值?
本文综述双能CT(DECT)技术原理、图像重建类型及专用软件,并汇总DECT评估弥漫性肝病(脂肪、铁、碘定量)及检测肝细胞癌的相关文献证据,探讨其在弥漫性肝病评估中的潜在作用。
要点
- DECT可准确识别和定量脂肪、铁、碘等多种物质,为弥漫性肝病评估提供定量信息。
- DECT在弥漫性肝病患者中检测和评估肝细胞癌具有附加价值证据。
- DECT技术、重建类型和专用软件是评估弥漫性肝病时需理解的基础。
临床应用与阅片要点
- DECT可准确识别和定量脂肪、铁和碘,可用于弥漫性肝病的评估。
- DECT在弥漫性肝病患者中检测和评估肝细胞癌具有附加价值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Dual-energy CT (DECT) can be defined as the use of two different energy levels to identify and quantify material composition. Since its inception, DECT has benefited from remarkable improvements in hardware and clinical applications. DECT enables accurate identification and quantification of multiple materials, including fat, iron, and iodine. As a consequence, multiple studies have investigated the potential role of DECT in the assessment of diffuse liver diseases. While this role is evolving, this article aims to review the most relevant literature on use of DECT for assessment of diffuse liver diseases. Moreover, the basic concepts on DECT techniques, types of image reconstruction, and DECT-dedicated software will be described, focusing on the areas that are most relevant for the evaluation of diffuse liver diseases. Also, we will review the evidence of added value of DECT in detection and assessment of hepatocellular carcinoma which is a known risk in patients with diffuse liver disease.
引用
- Elbanna KY, Mansoori B, Mileto A, et al. Dual-energy CT in diffuse liver disease: is there a role? Abdom Radiol (NY). 2020. PMID: 32772121. doi:10.1007/s00261-020-02702-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。